Clinical Trial Update: Modified Bortezomib-based Combination Therapy for Multiple Myeloma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on a modified bortezomib-based combination therapy for multiple myeloma, with current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Multiple Myeloma | Phase 4 | Status: UNKNOWN